Australia's most trusted
source of pharma news
Saturday, 06 July 2024
Posted 1 July 2024 PM
Three new drugs have been listed on the PBS this month, marking a milestone in what's been an arduous journey for some.
After two years of working through the reimbursement system, Jazz Pharmaceuticals has finally secured a PBS listing for its chemotherapy Vyxeos for newly diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.